Back to search

National and Kapodistrian University of Athens

Υποκλασματοποιημένο σχήμα εξωτερικής ακτινοθεραπείας (EBRT) σε ασθενείς με αδενοκαρκινώματα προστάτη αδένα: αξιολόγηση αποτελεσματικότητας και τοξικότητας

Abstract

dc:description

Background: Moderate hypofractionated radiotherapy (MHRT) has emerged as the preferred treatment modality for localized prostate cancer based on randomized controlled studies regarding efficacy and toxicity, using contemporary radiotherapy techniques. In the setting of MHRT, available data on dosimetric parameters and late rectal toxicity are limited. Aim: To present the effects of MHRT on late rectal toxicity while conducting an extensive dosimetric analysis in conjunction to rectoscopy results. Methods: This is a prospective study including patients with intermediate risk prostate adenocarcinoma. All patients were treated with MHRT 44 Gy in 16 fractions to the seminal vesicles and to the prostate followed by a sequential boost to the prostate alone of 16.5 Gy in 6 fractions delivered with three-dimensional conformal radiation therapy (3DCRT). Acute and late toxicity were assessed. Endoscopy was performed at baseline, every 3 months post-therapy for the first year and every 6 months for the year after. The Vienna Rectoscopy Score (VRS) was used to assess rectal mucosal injury related to radiotherapy. Dosimetric analysis for the rectum, rectal wall and its subsegments (upper, mid, and low 1/3) was performed. Results: Between September 2015 and December 2019, 20 patients enrolled. Grade 1 late gastrointestinal toxicity occurred in 10 % of the patients whereas 5% had grade ≥2. 12 months post radiotherapy: 4 (20%) patients had VRS 1; 2 (10%) patients had VRS 2; 1(5%) patient had VRS 3. 24 months post radiotherapy, VRS 1 was observed in 4 patients (20%) and VRS 2 in 3 (15%) patients. The dosimetric analysis demonstrated noticeable variations between the rectum, rectal wall, and rectal wall subsegments. The dosimetric analysis of rectum, rectal wall and its mid and low segments with respect to rectoscopy findings showed that the higher dose endpoints V52.17Gy and V56.52Gy are associated to rectal mucosal injury. Conclusion: A thorough delineation of the rectal wall and its subsegments together with the dosimetric analysis of these structures may reduce late rectal toxicity. Dosimetric parameters such as V52.17Gy and V56.52Gy were identified to have a significant impact to rectal mucosal injury; additional dose endpoint validation and its relation to late GI toxicity is needed.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kougioumtzopoulou, Andromachi
  • Κουγιουμτζοπούλου, Ανδρομάχη

Subjects

dc:subject × 24

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56565

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kougioumtzopoulou, Andromachi; Κουγιουμτζοπούλου, Ανδρομάχη. Υποκλασματοποιημένο σχήμα εξωτερικής ακτινοθεραπείας (EBRT) σε ασθενείς με αδενοκαρκινώματα προστάτη αδένα: αξιολόγηση αποτελεσματικότητας και τοξικότητας. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/56565